RNR · RenaissanceRe Holdings Ltd. Common Stock
View on chartInsiders & Stakes
| Kevin ODonnell Pres & Chief Executive Officer | ▼ Sell | Tax Withholding | 436,823 Shares held | 3/10/2026 | View profile |
| Ross Curtis EVP,Chief Portfolio Officer | ▼ Sell | Open Market | 170,991 Shares held | 8/17/2026 | View profile |
| David E. Marra EVP,Chief Underwriting Officer | ▼ Sell | Tax Withholding | 95,465 Shares held | 3/10/2026 | View profile |
| Robert Qutub EVP, Chief Financial Officer | ▼ Sell | Open Market | 72,907 Shares held | 7/28/2026 | View profile |
| BRANAGAN IAN D EVP, Group Chief Risk Officer | ▼ Sell | Tax Withholding | 69,202 Shares held | 9/1/2023 | View profile |
| Shannon Lowry Bender EVP, General Counsel & Secty | ▼ Sell | Tax Withholding | 36,122 Shares held | 3/10/2026 | View profile |
| James L. Gibbons Director | ▲ Buy | Grant | 32,462 Shares held | 3/1/2026 | View profile |
| HAMILTON JEAN D Director | ▲ Buy | Grant | 26,690 Shares held | 3/1/2022 | View profile |
| Gray Brian Gerald John Director | ▲ Buy | Grant | 25,118 Shares held | 3/1/2024 | View profile |
| Sean G. Brosnan SVP, Chief Investment Officer | ▲ Buy | Grant | 23,103 Shares held | 3/1/2026 | View profile |
| SANTOMERO ANTHONY M Director | ▲ Buy | Grant | 21,273 Shares held | 3/1/2023 | View profile |
| Henry Klehm III Director | ▲ Buy | Grant | 20,811 Shares held | 5/11/2026 | View profile |
| James Christopher Fraser SVP, Chief Accounting Officer | ▲ Buy | Grant | 15,097 Shares held | 3/1/2026 | View profile |
| David C. Bushnell Director | ▲ Buy | Grant | 13,439 Shares held | 3/1/2026 | View profile |
| Valerie Rahmani Director | ▲ Buy | Grant | 8,696 Shares held | 3/1/2026 | View profile |
| Duncan P. Hennes Director | ▲ Buy | Grant | 8,696 Shares held | 3/1/2026 | View profile |
| Cynthia Trudell Director | ▲ Buy | Grant | 6,534 Shares held | 3/1/2026 | View profile |
| Carol P. Sanders Director | ▼ Sell | Open Market | 5,762 Shares held | 5/18/2026 | View profile |
| Shyam H. Gidumal Director | ▲ Buy | Grant | 3,809 Shares held | 3/1/2026 | View profile |
| Torsten Jeworrek Director | ▲ Buy | Grant | 2,793 Shares held | 3/1/2026 | View profile |
| Loretta J. Mester Director | ▲ Buy | Grant | 1,865 Shares held | 3/1/2026 | View profile |
| Stephen C. Hooley Director | ▲ Buy | Grant | 591 Shares held | 5/11/2026 | View profile |
Transaction History
| Ross Curtis | ▼ Sell | Open Market | 5,000 | $1.6M | 8/17/2026 |
| Robert Qutub | ▼ Sell | Open Market | 1,582 | $525K | 7/28/2026 |
| Robert Qutub | ▼ Sell | Open Market | 2,640 | $880K | 7/28/2026 |
| Robert Qutub | ▼ Sell | Open Market | 778 | $260K | 7/28/2026 |
| Carol P. Sanders | ▼ Sell | Open Market | 1,479 | $440K | 5/18/2026 |
| Henry Klehm III | ▲ Buy | Grant | 506 | $0 | 5/11/2026 |
| Stephen C. Hooley | ▲ Buy | Grant | 591 | $0 | 5/11/2026 |
| David E. Marra | ▼ Sell | Tax Withholding | 2,630 | $782K | 3/10/2026 |
| Kevin ODonnell | ▼ Sell | Other | 2,424 | $0 | 3/10/2026 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 7,647 | $2.3M | 3/10/2026 |
| Ross Curtis | ▼ Sell | Other | 1,070 | $0 | 3/10/2026 |
| Robert Qutub | ▼ Sell | Other | 979 | $0 | 3/10/2026 |
| David E. Marra | ▼ Sell | Other | 652 | $0 | 3/10/2026 |
| Shannon Lowry Bender | ▼ Sell | Other | 483 | $0 | 3/10/2026 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 1,525 | $453K | 3/10/2026 |
| Robert Qutub | ▼ Sell | Tax Withholding | 3,087 | $918K | 3/10/2026 |
| Valerie Rahmani | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| James L. Gibbons | ▲ Buy | Grant | 1,074 | $0 | 3/1/2026 |
| Loretta J. Mester | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| David C. Bushnell | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| Duncan P. Hennes | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| Cynthia Trudell | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| Carol P. Sanders | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| Torsten Jeworrek | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| Robert Qutub | ▼ Sell | Tax Withholding | 432 | $131K | 3/1/2026 |
| Robert Qutub | ▼ Sell | Tax Withholding | 350 | $106K | 3/1/2026 |
| Robert Qutub | ▼ Sell | Tax Withholding | 329 | $100K | 3/1/2026 |
| Shannon Lowry Bender | ▲ Buy | Grant | 1,785 | $0 | 3/1/2026 |
| Shannon Lowry Bender | ▲ Buy | Grant | 5,356 | $0 | 3/1/2026 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 204 | $62K | 3/1/2026 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 213 | $64K | 3/1/2026 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 218 | $66K | 3/1/2026 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 263 | $80K | 3/1/2026 |
| Sean G. Brosnan | ▲ Buy | Grant | 6,343 | $0 | 3/1/2026 |
| Ross Curtis | ▲ Buy | Grant | 2,562 | $0 | 3/1/2026 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,068 | $323K | 3/1/2026 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,039 | $314K | 3/1/2026 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 977 | $296K | 3/1/2026 |
| David E. Marra | ▲ Buy | Grant | 2,975 | $0 | 3/1/2026 |
| David E. Marra | ▲ Buy | Grant | 8,926 | $0 | 3/1/2026 |
| David E. Marra | ▼ Sell | Tax Withholding | 254 | $77K | 3/1/2026 |
| David E. Marra | ▼ Sell | Tax Withholding | 317 | $96K | 3/1/2026 |
| David E. Marra | ▼ Sell | Tax Withholding | 382 | $116K | 3/1/2026 |
| James Christopher Fraser | ▲ Buy | Grant | 1,611 | $0 | 3/1/2026 |
| Ross Curtis | ▲ Buy | Grant | 7,686 | $0 | 3/1/2026 |
| Kevin ODonnell | ▲ Buy | Grant | 8,596 | $0 | 3/1/2026 |
| Kevin ODonnell | ▲ Buy | Grant | 25,788 | $0 | 3/1/2026 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,595 | $482K | 3/1/2026 |
| Henry Klehm III | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| Shyam H. Gidumal | ▲ Buy | Grant | 578 | $0 | 3/1/2026 |
| Robert Qutub | ▲ Buy | Grant | 2,644 | $0 | 3/1/2026 |
| Robert Qutub | ▲ Buy | Grant | 7,934 | $0 | 3/1/2026 |
| Robert Qutub | ▼ Sell | Tax Withholding | 517 | $156K | 3/1/2026 |
| David E. Marra | ▼ Sell | Tax Withholding | 1,271 | $383K | 2/15/2026 |
| Robert Qutub | ▼ Sell | Open Market | 2,284 | $698K | 2/6/2026 |
| Robert Qutub | ▼ Sell | Open Market | 2,716 | $831K | 2/6/2026 |
| Ross Curtis | ▼ Sell | Open Market | 5,000 | $1.5M | 2/5/2026 |
| Ross Curtis | ▼ Sell | Open Market | 5,000 | $1.4M | 2/4/2026 |
| Ross Curtis | ▼ Sell | Open Market | 5,000 | $1.5M | 2/4/2026 |
| Ross Curtis | ▼ Sell | Open Market | 5,000 | $1.5M | 2/4/2026 |
| David E. Marra | ▼ Sell | Tax Withholding | 653 | $166K | 11/1/2025 |
| David C. Bushnell | ▼ Sell | Open Market | 2,544 | $609K | 8/12/2025 |
| David C. Bushnell | ▼ Sell | Open Market | 1,300 | $312K | 8/12/2025 |
| David C. Bushnell | ▼ Sell | Open Market | 1,700 | $411K | 8/12/2025 |
| David C. Bushnell | ▼ Sell | Open Market | 300 | $73K | 8/12/2025 |
| David E. Marra | ▼ Sell | Open Market | 1,000 | $237K | 7/16/2025 |
| James Christopher Fraser | ▼ Sell | Open Market | 11,821 | $3.0M | 5/8/2025 |
| James Christopher Fraser | ▼ Sell | Open Market | 1,847 | $464K | 5/8/2025 |
| James Christopher Fraser | ▼ Sell | Open Market | 332 | $83K | 5/7/2025 |
| Kevin ODonnell | ▼ Sell | Other | 3,447 | $0 | 3/11/2025 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 11,478 | $2.7M | 3/11/2025 |
| Ross Curtis | ▼ Sell | Other | 1,246 | $0 | 3/11/2025 |
| Robert Qutub | ▼ Sell | Other | 1,117 | $0 | 3/11/2025 |
| Robert Qutub | ▼ Sell | Tax Withholding | 3,719 | $890K | 3/11/2025 |
| Robert Qutub | ▼ Sell | Tax Withholding | 407 | $97K | 3/1/2025 |
| Robert Qutub | ▼ Sell | Tax Withholding | 517 | $123K | 3/1/2025 |
| Robert Qutub | ▼ Sell | Tax Withholding | 432 | $103K | 3/1/2025 |
| Robert Qutub | ▼ Sell | Tax Withholding | 350 | $83K | 3/1/2025 |
| James L. Gibbons | ▲ Buy | Grant | 1,325 | $0 | 3/1/2025 |
| Torsten Jeworrek | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 183 | $43K | 3/1/2025 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 204 | $48K | 3/1/2025 |
| Sean G. Brosnan | ▲ Buy | Grant | 3,866 | $0 | 3/1/2025 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 214 | $51K | 3/1/2025 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 218 | $52K | 3/1/2025 |
| Kevin ODonnell | ▲ Buy | Grant | 10,552 | $0 | 3/1/2025 |
| Kevin ODonnell | ▲ Buy | Grant | 21,104 | $0 | 3/1/2025 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,330 | $316K | 3/1/2025 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,594 | $379K | 3/1/2025 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,068 | $254K | 3/1/2025 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,039 | $247K | 3/1/2025 |
| Duncan P. Hennes | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| Shyam H. Gidumal | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| Henry Klehm III | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| James Christopher Fraser | ▲ Buy | Grant | 2,472 | $0 | 3/1/2025 |
| Valerie Rahmani | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| David E. Marra | ▲ Buy | Grant | 4,734 | $0 | 3/1/2025 |
| David E. Marra | ▲ Buy | Grant | 9,468 | $0 | 3/1/2025 |
| David E. Marra | ▼ Sell | Tax Withholding | 368 | $87K | 3/1/2025 |
| David E. Marra | ▼ Sell | Tax Withholding | 463 | $110K | 3/1/2025 |
| Carol P. Sanders | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| Loretta J. Mester | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| Robert Qutub | ▲ Buy | Grant | 3,550 | $0 | 3/1/2025 |
| Robert Qutub | ▲ Buy | Grant | 7,100 | $0 | 3/1/2025 |
| David C. Bushnell | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| Ross Curtis | ▲ Buy | Grant | 3,813 | $0 | 3/1/2025 |
| Ross Curtis | ▲ Buy | Grant | 7,626 | $0 | 3/1/2025 |
| Cynthia Trudell | ▲ Buy | Grant | 694 | $0 | 3/1/2025 |
| Shannon Lowry Bender | ▲ Buy | Grant | 2,840 | $0 | 3/1/2025 |
| Shannon Lowry Bender | ▲ Buy | Grant | 5,680 | $0 | 3/1/2025 |
| David E. Marra | ▼ Sell | Tax Withholding | 781 | $180K | 2/15/2025 |
| David E. Marra | ▼ Sell | Tax Withholding | 1,259 | $291K | 2/15/2025 |
| David E. Marra | ▼ Sell | Open Market | 1,000 | $254K | 1/15/2025 |
| Henry Klehm III | ▼ Sell | Open Market | 16 | $4K | 11/18/2024 |
| Henry Klehm III | ▼ Sell | Gift | 131 | $0 | 11/18/2024 |
| Henry Klehm III | ▼ Sell | Open Market | 1,731 | $446K | 11/18/2024 |
| David E. Marra | ▼ Sell | Open Market | 1,000 | $260K | 11/14/2024 |
| Loretta J. Mester | ▲ Buy | Grant | 593 | $0 | 11/6/2024 |
| David E. Marra | ▼ Sell | Tax Withholding | 652 | $172K | 11/1/2024 |
| David E. Marra | ▼ Sell | Open Market | 1,000 | $279K | 10/4/2024 |
| David E. Marra | ▼ Sell | Open Market | 1,000 | $269K | 9/26/2024 |
| David E. Marra | ▼ Sell | Open Market | 750 | $194K | 8/29/2024 |
| David E. Marra | ▼ Sell | Open Market | 750 | $187K | 8/23/2024 |
| Robert Qutub | ▼ Sell | Open Market | 2,500 | $561K | 7/26/2024 |
| David E. Marra | ▼ Sell | Open Market | 1,000 | $230K | 7/17/2024 |
| David C. Bushnell | ▼ Sell | Open Market | 2,000 | $445K | 5/15/2024 |
| Kevin ODonnell | ▼ Sell | Other | 1,437 | $0 | 3/18/2024 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 10,106 | $2.4M | 3/18/2024 |
| Robert Qutub | ▼ Sell | Other | 439 | $0 | 3/18/2024 |
| Robert Qutub | ▼ Sell | Tax Withholding | 3,089 | $727K | 3/18/2024 |
| Ross Curtis | ▼ Sell | Other | 467 | $0 | 3/18/2024 |
| David E. Marra | ▼ Sell | Open Market | 750 | $179K | 3/15/2024 |
| David E. Marra | ▲ Buy | Grant | 7,834 | $0 | 3/1/2024 |
| Robert Qutub | ▼ Sell | Tax Withholding | 407 | $91K | 3/1/2024 |
| David E. Marra | ▼ Sell | Tax Withholding | 367 | $82K | 3/1/2024 |
| Robert Qutub | ▼ Sell | Tax Withholding | 432 | $96K | 3/1/2024 |
| Carol P. Sanders | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| David E. Marra | ▲ Buy | Grant | 3,917 | $0 | 3/1/2024 |
| Cynthia Trudell | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| Robert Qutub | ▼ Sell | Tax Withholding | 517 | $115K | 3/1/2024 |
| Valerie Rahmani | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| David C. Bushnell | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 183 | $41K | 3/1/2024 |
| Henry Klehm III | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| James Christopher Fraser | ▲ Buy | Grant | 1,511 | $0 | 3/1/2024 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 204 | $46K | 3/1/2024 |
| Shannon Lowry Bender | ▼ Sell | Tax Withholding | 213 | $48K | 3/1/2024 |
| Sean G. Brosnan | ▲ Buy | Grant | 4,175 | $0 | 3/1/2024 |
| Duncan P. Hennes | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| James L. Gibbons | ▲ Buy | Grant | 1,410 | $0 | 3/1/2024 |
| Gray Brian Gerald John | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| Ross Curtis | ▲ Buy | Grant | 4,057 | $0 | 3/1/2024 |
| Ross Curtis | ▲ Buy | Grant | 8,114 | $0 | 3/1/2024 |
| Torsten Jeworrek | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| Robert Qutub | ▲ Buy | Grant | 3,777 | $0 | 3/1/2024 |
| Robert Qutub | ▲ Buy | Grant | 7,554 | $0 | 3/1/2024 |
| Robert Qutub | ▼ Sell | Tax Withholding | 456 | $102K | 3/1/2024 |
| Kevin ODonnell | ▲ Buy | Grant | 11,226 | $0 | 3/1/2024 |
| Kevin ODonnell | ▲ Buy | Grant | 22,452 | $0 | 3/1/2024 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,270 | $284K | 3/1/2024 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,330 | $297K | 3/1/2024 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,595 | $356K | 3/1/2024 |
| Kevin ODonnell | ▼ Sell | Tax Withholding | 1,068 | $239K | 3/1/2024 |
| Shyam H. Gidumal | ▲ Buy | Grant | 738 | $0 | 3/1/2024 |
| Shannon Lowry Bender | ▲ Buy | Grant | 2,350 | $0 | 3/1/2024 |
| Shannon Lowry Bender | ▲ Buy | Grant | 4,700 | $0 | 3/1/2024 |
| David E. Marra | ▼ Sell | Tax Withholding | 1,400 | $320K | 2/15/2024 |
| David E. Marra | ▼ Sell | Tax Withholding | 768 | $176K | 2/15/2024 |
| David E. Marra | ▼ Sell | Tax Withholding | 362 | $83K | 2/15/2024 |
| David E. Marra | ▼ Sell | Tax Withholding | 1,259 | $288K | 2/15/2024 |
| Carol P. Sanders | ▼ Sell | Open Market | 55 | $13K | 2/12/2024 |
| Carol P. Sanders | ▼ Sell | Open Market | 825 | $188K | 2/12/2024 |
| Carol P. Sanders | ▼ Sell | Gift | 132 | $0 | 2/12/2024 |
| Robert Qutub | ▼ Sell | Open Market | 1,329 | $312K | 2/7/2024 |
| Robert Qutub | ▼ Sell | Open Market | 1,171 | $275K | 2/7/2024 |
| David E. Marra | ▼ Sell | Open Market | 750 | $172K | 1/31/2024 |
| David E. Marra | ▼ Sell | Open Market | 1,000 | $209K | 1/17/2024 |
| Sean G. Brosnan | ▲ Buy | Grant | 1,641 | $0 | 12/1/2023 |
| James Christopher Fraser | ▲ Buy | Grant | 1,641 | $0 | 12/1/2023 |
| Robert Qutub | ▼ Sell | Open Market | 1,000 | $211K | 11/21/2023 |
| Robert Qutub | ▼ Sell | Open Market | 3,110 | $665K | 11/21/2023 |
| Robert Qutub | ▼ Sell | Open Market | 2,990 | $643K | 11/21/2023 |
| Robert Qutub | ▼ Sell | Open Market | 400 | $86K | 11/21/2023 |
| David E. Marra | ▼ Sell | Open Market | 1,000 | $208K | 11/20/2023 |
| Robert Qutub | ▲ Buy | Grant | 7,233 | $0 | 11/7/2023 |
| Ross Curtis | ▲ Buy | Grant | 7,233 | $0 | 11/7/2023 |
| David E. Marra | ▲ Buy | Grant | 7,233 | $0 | 11/7/2023 |
| Shannon Lowry Bender | ▲ Buy | Grant | 7,233 | $0 | 11/7/2023 |
| Kevin ODonnell | ▲ Buy | Grant | 69,444 | $0 | 11/7/2023 |
| Kevin ODonnell | ▲ Buy | Grant | 23,148 | $0 | 11/7/2023 |
| David E. Marra | ▼ Sell | Tax Withholding | 653 | $148K | 11/1/2023 |
| Henry Klehm III | ▲ Buy | Open Market | 13 | $3K | 10/25/2023 |
| BRANAGAN IAN D | ▼ Sell | Tax Withholding | 575 | $109K | 9/1/2023 |
| BRANAGAN IAN D | ▼ Sell | Tax Withholding | 1,058 | $201K | 9/1/2023 |
| BRANAGAN IAN D | ▼ Sell | Tax Withholding | 2,020 | $383K | 9/1/2023 |
| BRANAGAN IAN D | ▼ Sell | Tax Withholding | 2,116 | $401K | 9/1/2023 |
| Kevin ODonnell | ▲ Buy | Open Market | 13,020 | $2.5M | 5/26/2023 |
| Henry Klehm III | ▼ Sell | Gift | 263 | $0 | 5/25/2023 |
| Torsten Jeworrek | ▲ Buy | Grant | 783 | $0 | 5/9/2023 |
| James Christopher Fraser | ▲ Buy | Grant | 475 | $0 | 5/9/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
RenaissanceRe Q2 2026 Earnings Call Highlights Discounted Valuation
During the Q2 2026 earnings call, RenaissanceRe reiterated its diversified reinsurance strategy and maintained a cautious outlook. Analysts noted the stock trades at a discount to peers, with a 142% run and a P/E of 5.2, suggesting potential undervaluation. The company’s dividend yield of 0.69% and analyst target of $346.40 contrast with its current price near the 52‑week low of $231.17. RSI sits at 45.5 and the support level at $292.90 adds context to its valuation debate.
RenaissanceRe Q2 2026 Earnings Call Highlights Discounted Valuation. During the Q2 2026 earnings call, RenaissanceRe reiterated its diversified reinsurance strategy and maintained a cautious outlook. Analysts noted the stock trades at a discount to peers, with a 142% run and a P/E of 5.2, suggesting potential undervaluation. The company’s dividend yield of 0.69% and analyst target of $346.40 contrast with its current price near the 52‑week low of $231.17. RSI sits at 45.5 and the support level at $292.90 adds context to its valuation debate.